FIELD: medicine.
SUBSTANCE: invention relates to medicine, pediatrics and allergology. Pregnant woman with allergopathy at the term of 35–36 weeks of gestation is prescribed a course of probiotics containing the Lactobacillus acidophilus NK-1 lactobacillus strain 1 capsule 3 times a day. Rectally, 2 times a day for 10 days, a drug containing interferon alfa-2b and an antioxidant is introduced, 1 suppository each time. Newborn child is given a course of a probiotic containing strains of Lactobacillus rhamnosus GG, 1 sachet per day for 14 days. Drug interferon alpha-2b with an antioxidant is introduced by 1 suppository rectally 2 times a day for 5 days.
EFFECT: method provides primary prevention of allergopathology and atopic dermatitis by modulating the microbial mechanism of histamine formation in newborns at risk.
1 cl, 3 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR PREDICTION OF ATOPIC DERMATITIS DEVELOPMENT IN INFANTS | 2016 |
|
RU2635768C1 |
| PROBIOTICS FOR REDUCING RISK OF OBESITY | 2008 |
|
RU2464994C2 |
| SPECIALISED PRODUCT WITH A PROBIOTIC BASED ON A COMPLETE WHEY PROTEIN HYDROLYSATE FOR NUTRITION OF CHILDREN FROM BIRTH | 2020 |
|
RU2761534C1 |
| USING LACTOBACILLUS REUTERI FOR RECOVERING MICROBIOTA AFTER DYSBIOSIS AT EARLY STAGES OF DEVELOPMENT | 2015 |
|
RU2723687C2 |
| METHOD FOR REDUCING THE CLINICAL MANIFESTATIONS OF ATOPIC DERMATITIS IN BREASTFED CHILDREN | 2022 |
|
RU2794207C1 |
| APPLICATION OF INDIGESTIBLE SACCHARIDES FOR BETTER ADAPTATION OF NEWBORNS | 2007 |
|
RU2462252C2 |
| USE OF LACTIC ACID BACTERIA FOR TREATING OR PREVENTING GESTATIONAL DIABETES MELLITUS | 2017 |
|
RU2769312C2 |
| HEALTH-IMPROVING COMPOSITION FOR ADMINISTRATION IN FORM OF DROPS AND SUCH COMPOSITION PRODUCTION METHOD | 2010 |
|
RU2524656C2 |
| METHOD OF PREVENTION OF ATOPIC DERMATITIS IN YOUNG CHILDREN | 2017 |
|
RU2675254C1 |
| PROBIOTIC COMPOSITION INTENDED FOR BABIES WITH LOW BODY WEIGHT AT BIRTH | 2009 |
|
RU2509478C2 |
